![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PerkinElmer, Predictive Announce Alzheimer's Biomarkers Discovery
PerkinElmer, Predictive Announce Alzheimer's Biomarkers Discovery
April 21, 2005
PerkinElmer, a provider of drug discovery, life science research and analytical solutions, and Predictive Diagnostics, a wholly owned subsidiary of Large Scale Biology, announced that they have found a series of biomarkers that appear to differ in persons with Alzheimer 's disease compared to persons without cognitive impairment, using a simple blood test.
ArriveNet
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct